Start
Completion

Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment

Not yet recruitingRegisteredCTG

This interventional trial (n=10) will explore the impact of audiovisual stimuli using virtual reality on the tolerability and effectiveness of ketamine/esketamine treatment for depressive episodes.

Details

Single-group study of virtual reality gear and content provided during a single ketamine/esketamine treatment session in patients on maintenance treatment for depression to assess tolerability and treatment effectiveness.

Outcomes include measures of tolerability, patient-reported experience, and depressive symptom change following the treatment session.

Topics:Depressive Disorders

Registry

Registry linkNCT06139016